Posted on by lowes1

A Study Evaluating the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Patients With Uncontrolled Asthma

Condition:   Asthma
Interventions:   Drug: lebrikizumnab;   Other: placebo
Sponsor:   Hoffmann-La Roche
Not yet recruiting – verified March 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.